International Atherosclerosis Society Residual Risk Reductio...
MILAN and BASEL, Switzerland Sept. 3, 2019 AsiaNet /PRNewswire/ -- A new highly selective treatment, a peroxisome proliferator-activated receptor alpha modulator (SPPARM-alpha) agonist, may help to address the gap in managing the residual risk of heart attacks and strokes in high-risk patients, according to over ...
Authors: LATEST ASIANET NEWS RELEASES